Patent · US Expired

Melanocortin receptor agonists

US7291619B2 · kind B2 · utility

1Cited by

3References

23Claims

0Family size

Assignee

ELI LILLY AND COMPANY · US

Inventors

Christopher Kelly Biggers · Clayton, US
Karin Briner · Indianapolis, US
Christopher William Doecke · Indianapolis, US
Matthew Joseph Fisher · Mooresville, US
Larry W. Hertel · Indianapolis, US
Vincent Mancuso · Thy-le-Château, BE
Michael John Martinelli · Indianapolis, US
John Philip Mayer · Boulder, US
Paul Leslie Ornstein · Carmel, US
Timothy Ivo Richardson · Zionsville, US
Jikesh Arvind Shah · Greenwood, US
Qing Shi · Princeton, US
Zhipei Wu · Fishers, US
Chaoyu Xie · Carmel, US

Key dates

Filing date	Jan 23, 2002
Grant date	Nov 6, 2007
Priority date	—
Expiry date	Oct 8, 2022

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to melanocortin receptor agonists of formula (I), which is useful in the treatment of obesity, diabetes and male and/or female sexual dysfunction

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.